About Terramera
Terramera is a Chemicals & Materials company based in Vancouver (Canada) founded in 2010 by Karn Manhas. Plant-based biopesticides are developed for agricultural applications by Terramera. It operates in the Chemicals & Materials and Agriculture sectors. Terramera has raised $64.94 million across 9 funding rounds from investors including BDC, Acai SG and At One Ventures. The company has 16 employees. Its chief executive, as recorded, is Nate Kelly. Its Indian entity Terramera Biosciences (India) Private Limited reported revenue of ₹8.19 Cr. Terramera offers products and services including Rango, Socoro, Catalera, and Miraterra. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Biologicals.
Company details
Founded in 2010 and based in Vancouver, Canada, Terramera operates in the biopesticides sector. Plant-derived products such as Rango and Terraneem are offered in its catalog. These solutions are applied in conventional and organic farming, as well as professional and residential settings. Operations focus on sustainable pest management alternatives within the agriculture industry.
- Headquarters Vancouver, Canada
- Employees 16
- Founders Karn Manhas
- SectorsChemicals & MaterialsAgriculture
- Email••••••••
- Phone•••• ••••
- Website terramera.com
- Social LinkedIn X Facebook Instagram
- Legal Name Terramera Biosciences (India) Private Limited
- Date of Incorporation 29 Aug, 2012
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹8.19 Cr
FY 2025 · +1220% YoY
- Indian entity net loss-₹1.42 Cr
FY 2025 · -17% margin
- Indian entity EBITDA-₹2.01 Cr
FY 2025 · -25% margin
- Total Equity Funding$64.94M (USD)
in 9 rounds
- Latest Funding Round$6M (USD), Series C
Jan 2023
- InvestorsBDC
& 10 more
- Employee Count16
Associated legal entities of Terramera
Terramera operates through Terramera Biosciences (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Terramera Biosciences (India) Private Limited CIN U40104TN2012FTC087406 | Active | 29 Aug 2012 | Chennai, Tamil Nadu | ₹8.2 Cr | 16 | 3 | View details |
Products & Services of Terramera
Terramera offers a comprehensive portfolio of products and services, including Rango, Socoro, Catalera, and Miraterra.
Provides broad range control as fungicide, insecticide, and miticide.
Manages insects, mites, and diseases in soybean and corn crops.
Enables rapid testing and tailored formulations for bio-based products.
Offers accurate soil measurement using AI and machine learning.
Funding Insights of Terramera
Terramera has successfully raised a total of $64.94M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $6 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $64.94M
- Total Rounds 9
- Last Round Series C — $6M
- First Round $10M
(May 2016)
- Investors Count 11
All 9 funding rounds of Terramera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $6M | Series C | – | At One Ventures | – |
| Apr 2022 | $1M | Grant | – | – | |
| May 2021 | $7.9M | Grant | – | – | |
| Jan 2020 | $3.49M | Series B | – | S2G Ventures, Ospraie Ag Science | |
| Aug 2019 | $45.45M | Series B | – | S2G Ventures, Ospraie Ag Science | – |
| Feb 2019 | $9.86M | Debt – Conventional | – | – | |
| Jun 2018 | $1.9M | Grant | – | – | |
| Sep 2016 | Series B | – | – | ||
| May 2016 | $10M | Series A | – | S2G Ventures |
11 investors in total: 11 institutional.
Investors in Terramera
Terramera has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include BDC, Acai SG and At One Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| atoneventures.com | ||||
Venture capital firm focused on investing in clean tech sectors | sdtc.ca | Ottawa, Canada | ||
Venture capital firm focused on multiple sectors | arcternventures.com | Toronto, Canada | ||
Stage agnostic venture capital firm | s2gventures.com | Chicago, United States | ||
Solutions are identified by Ospraie Ag Science for sustainable farming. | ospraieagscience.com | Rye, United States | ||
| greentechab.com | ||||
Private equity investment firm focused on growth stage companies | 2008 | acaisg.com | Singapore, Singapore | |
Early-stage life sciences and tech focused VC firm investing primarily in the US | boldcapitalpartners.com | Santa Monica, United States | ||
Renewal Funds is engaged in impact investing for sustainable change. | renewalfunds.com | |||
Venture capital investments are made in agricultural innovation by Maumee Ventures. | 1947 | maumeeventures.com | Maumee, United States |
Investor details for Terramera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Terramera Biosciences (India) Private Limited (Terramera)
Terramera Biosciences (India) Private Limited is the primary company behind Terramera. The board of Terramera Biosciences (India) Private Limited currently have 3 directors; the longest-serving is Maxwell Nirmal Kumar Samuel, appointed in 2014. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Maxwell Nirmal Kumar Samuel DIN 01960781 | Director | 25 Sep 2014 | 12 yrs 1 mo | Terramera Biosciences (India) Private Limited |
| Nathanael Baron Kelly DIN 10742184 | Director | 29 Aug 2024 | 2 yrs 2 mo | Terramera Biosciences (India) Private Limited |
| Matthew Dahabieh DIN 10742172 | Director | 29 Aug 2024 | 2 yrs 2 mo | Terramera Biosciences (India) Private Limited |
People of Terramera
23 people are tracked at Terramera (4 in leadership, 13 in board & advisors, 6 in team); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
Karn Manhas | Founder & Chairman | Leadership |
Nate Kelly | CEO | Leadership |
Graeme Herring | VP, Intellectual Property Strategy | Leadership |
Brent Palmer | Director, Facilities | Leadership |
Sanjeev Krishnan | Board Member | Board & advisors |
Alex Lau | Board Member | Board & advisors |
Sanjay Lashand | Strategic Advisor | Board & advisors |
Santa Ono | Strategic Advisor | Board & advisors |
Adrian Percy | Advisor | Board & advisors |
Greg D'Avignon | Advisor | Board & advisors |
Carl Casale | Board Member | Board & advisors |
Nancy Roman | Advisor | Board & advisors |
Jeff Booth | Board Member | Board & advisors |
Diana Fox Carney | Strategic Advisor | Board & advisors |
Markita Landry | Advisor | Board & advisors |
Stewart Beck | Advisor | Board & advisors |
Tom Chi | Advisor | Board & advisors |
Cormac O'Cleirigh | Business Development Executive | Team |
Christopher Scott | General Counsel | Team |
Nick Dearing | Information Technology Technician | Team |
3 more people are available in the full profile.
Complete people profiles for Terramera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Terramera
Figures of Terramera Biosciences (India) Private Limited, the primary company behind Terramera, for FY 2025. Revenue was ₹8.19 Cr (+1220% year on year). Net loss was -₹1.42 Cr (-17% margin). EBITDA was -₹2.01 Cr (-25% margin). Revenue has grown at a compounded annual rate of -34% over three years and -3% over five years.
- ₹8.19 CrRevenue · FY 2025 · +1220% YoY
- -₹1.42 CrNet loss · -17% margin
- -₹2.01 CrEBITDA · -25% margin
- ₹31.1 LakhPaid-up capital
- 16Employees (provident fund records)
- -34%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Terramera Biosciences (India) Private Limited are on its company page.
Detailed financial statements for Terramera
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Terramera
3 dated milestones of Terramera across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Terramera is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series C, of $6.0M.
Web traffic of Terramera
The website of Terramera (terramera.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▼ 20.4% vs previous month
Websites whose visitors overlap most with Terramera. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cdnstrategy.com | cdnstrategy.com | 100% | #12,439,002 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Terramera
Complete news archive for Terramera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Terramera
Terramera was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Terramera is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Nate Kelly is the CEO of Terramera, as recorded in our data.
Terramera is a funded company, having raised a total of $64.94M across 9 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on May 2016.
Terramera has 16 employees.
The primary company behind Terramera, Terramera Biosciences (India) Private Limited, reported revenue of ₹8.19 Cr for FY 2025, up 1220% year on year.
Founded in 2010 and based in Vancouver, Canada, Terramera operates in the biopesticides sector. Plant-derived products such as Rango and Terraneem are offered in its catalog. These solutions are applied in conventional and organic farming, as well as professional and residential settings. Operations focus on sustainable pest management alternatives within the agriculture industry.
Terramera offers Rango, Socoro, Catalera, and Miraterra.
Terramera has 11 investors. Key investors include BDC, Acai SG, At One Ventures, Sustainable Development Technology Canada, and ArcTern Ventures.
Terramera operates through Terramera Biosciences (India) Private Limited.
The legal entities of Terramera currently have 3 directors, including Nathanael Baron Kelly, Matthew Dahabieh, Maxwell Nirmal Kumar Samuel.